Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 67.54B | 67.54B | 65.02B | 58.06B | 45.82B | 40.15B |
Gross Profit | 16.40B | 16.40B | 16.37B | 13.16B | 8.47B | 6.16B |
EBITDA | 30.63B | 30.63B | 34.95B | 33.35B | 24.26B | 17.11B |
Net Income | 2.81B | 2.81B | 5.19B | 6.44B | 3.28B | 1.25B |
Balance Sheet | ||||||
Total Assets | 293.28B | 293.28B | 276.46B | 274.95B | 237.57B | 205.10B |
Cash, Cash Equivalents and Short-Term Investments | 48.22B | 48.22B | 38.31B | 27.57B | 23.66B | 21.12B |
Total Debt | 165.70B | 165.70B | 167.38B | 181.19B | 173.73B | 153.29B |
Total Liabilities | 202.06B | 202.06B | 195.04B | 206.51B | 190.19B | 166.36B |
Stockholders Equity | 47.76B | 47.76B | 42.77B | 35.33B | 23.97B | 19.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 20.93B | 18.13B | -2.02B | -17.87B | -36.80B |
Operating Cash Flow | 0.00 | 30.20B | 27.95B | 26.38B | 19.90B | 13.14B |
Investing Cash Flow | 0.00 | -6.75B | 8.49B | -18.42B | -31.48B | -40.57B |
Financing Cash Flow | 0.00 | -13.51B | -24.60B | -5.46B | 12.03B | 29.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥22.89B | 4.79 | 0.69% | 2.23% | 0.81% | ||
79 Outperform | ¥146.87B | 14.21 | 2.33% | 2.94% | 2.46% | ||
77 Outperform | ¥118.34B | 18.87 | 2.48% | 8.81% | -42.49% | ||
68 Neutral | ¥315.52B | 30.32 | 2.31% | 10.96% | -8.63% | ||
68 Neutral | ¥232.27B | 11.87 | 3.35% | 5.69% | 65.59% | ||
64 Neutral | $10.85B | 16.20 | 8.89% | 1.97% | 2.67% | -15.04% |